Gabapentin Capsule
Product Images NDC 63739-902

9 FDA label images from Mckesson Corporation Dba Sky Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63739-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mckesson Corporation Dba Sky Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
A text panel showing the formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a factor for female patients. This formula supports dosing considerations but does not provide specific drug instructions.*
FDA Label Image

Structure (Gabapentin Str)

Structure (Gabapentin Str)
Chemical structure diagram of Gabapentin showing a cyclohexane ring bonded to amine and carboxyl functional groups.*
FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
A line graph showing mean pain scores over an 8-week period comparing placebo with Gabapentin at 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing trend in pain scores over time compared to placebo.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
A line graph showing mean pain scores over 7 weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. Gabapentin groups show a decline in pain scores more than placebo over time.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
A bar graph depicting the proportion of responders with at least 50% reduction in pain score at the endpoint of controlled PHN studies. The graph compares placebo (PBO) and Gabapentin (GBP) at doses of 3600 mg in Study 1, and 1800 mg and 2400 mg in Study 2, showing higher responder rates for Gabapentin groups versus placebo.*
FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

Gabapentin-fig4.jpg (Gabapentin Fig4)
A chart comparing the difference in percentage on the vertical axis against daily dose in mg on the horizontal axis, showing data points for three studies labeled as Study a, Study b, and Study c. Study a is represented by black squares, Study b by gray squares, and Study c by white squares, with data points at various daily dose levels from approximately 600 mg to 1800 mg.*
FDA Label Image

Gabapentin-100mg-cap1a (Gabapentin 100mg Cap1a)

Gabapentin-100mg-cap1a (Gabapentin 100mg Cap1a)
Box packaging label for Gabapentin Capsules USP, 100 mg strength. The label shows a quantity of 100 unit dose capsules (10 x 10) and is marked Rx Only. The labeler is McKesson Corporation dba Sky Packaging, with manufacturing by Alkem Laboratories Ltd., India. Storage instructions and a barcode are also visible on the label.*
FDA Label Image

Gabapentin-300mg-cap1a (Gabapentin 300mg Cap1a)

Gabapentin-300mg-cap1a (Gabapentin 300mg Cap1a)
Gabapentin Capsules, USP 300 mg packaging label from McKesson Corporation dba SKY Packaging. The label indicates the product is for oral use, containing 100 unit dose capsules (10 x 10). The capsules each contain 300 mg of Gabapentin. Storage instructions advise keeping at 20° to 25°C. Manufactured by Alkem Laboratories Ltd., India.*
FDA Label Image

Gabapentin-400mg-cap1a (Gabapentin 400mg Cap1a)

Gabapentin-400mg-cap1a (Gabapentin 400mg Cap1a)
Box packaging label for Gabapentin Capsules, USP 400 mg by McKesson Corporation dba Sky Packaging. The label highlights 100 (10 x 10) unit dose capsules. It advises pharmacists to dispense the enclosed medication guide and provides storage instructions at controlled room temperature. Manufactured by Alkem Laboratories Ltd., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.